These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 54269)

  • 21. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 22. Demonstration of specific T-lymphocyte membrane antigens associated with antibodies inhibiting the mixed leukocyte culture in man.
    Wernet P; Kunkel HG
    Transplant Proc; 1973 Dec; 5(4):1875-81. PubMed ID: 4130086
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro secondary MLR. III: Hybrid histocompatibility determinants.
    Fathman CG; Watanabe T; Augustin A
    J Immunol; 1978 Jul; 121(1):259-64. PubMed ID: 78942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T lymphocyte responses to non-H-2 histocompatibility antigens. I. Role of Ly-1+2+ T cells as cytotoxic effectors and requirement for Ly-1+2+ T cells for optimal generation of cytotoxic effectors.
    Wettstein PJ; Frelinger JA
    J Immunol; 1981 Jul; 127(1):43-6. PubMed ID: 6165773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Ia antigens on T and B cells and their relationship to immune-response functions.
    Niederhuber JE; Frelinger JA
    Transplant Rev; 1976; 30():101-21. PubMed ID: 59969
    [No Abstract]   [Full Text] [Related]  

  • 27. SD vs. LD antigens as targets for lymphocyte-mediated cytotoxicity: study of a family presenting a recombination event within the MHR.
    Bonnard GD; Chappuis M; Glauser A; Mempel W; Baumann P; Grosse-Wilde H; Albert ED
    Transplant Proc; 1973 Dec; 5(4):1679-82. PubMed ID: 4130076
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of murine T-cell cytotoxicity by preimmunization with M locus and H-2 incompatibilities.
    Matossian-Rogers A; Festenstein H
    J Exp Med; 1976 Feb; 143(2):456-61. PubMed ID: 55455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
    Perlmann P; Holm G; Stejskal V
    Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
    [No Abstract]   [Full Text] [Related]  

  • 30. The association between the HLA system and disease.
    McMichael A; McDevitt H
    Prog Med Genet; 1977; 2():39-100. PubMed ID: 142998
    [No Abstract]   [Full Text] [Related]  

  • 31. A brief review of immune-response genes in mice.
    Günther E
    Transplant Proc; 1973 Dec; 5(4):1315-9. PubMed ID: 4130052
    [No Abstract]   [Full Text] [Related]  

  • 32. Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors.
    Bevan MJ
    J Immunol; 1975 Jan; 114(1 Pt 2):316-9. PubMed ID: 123256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral factors. Immunologic enhancement.
    Batchelor JR; Welsh KI; Burgos H
    Transplant Proc; 1977 Mar; 9(1):931-6. PubMed ID: 141143
    [No Abstract]   [Full Text] [Related]  

  • 34. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

  • 35. Priming for a cytotoxic response to minor histocompatibility antigens: antigen specificity and failure to demonstrate a carrier effect.
    Bevan MJ
    J Immunol; 1977 Apr; 118(4):1370-4. PubMed ID: 66290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The xenogeneic effect. III. Induction of cell-mediated cytotoxicity by alloantigen-stimulated thymocytes in the presence of xenogeneic reconstitution factor.
    Simon PL; Farrar JJ; Kind PD
    J Immunol; 1977 Apr; 118(4):1129-31. PubMed ID: 66277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic requirements for the generation of secondary cytotoxicity.
    Grillot-Courvalin C; Alter BJ; Bach FH
    J Immunol; 1977 Oct; 119(4):1253-9. PubMed ID: 142790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific lymphoblastoid cell lines: possible methods for establishment and potential application in systems of delayed hypersensitivity.
    Sondel PM; Bach FH
    Birth Defects Orig Artic Ser; 1973 Jan; 9(1):98-110. PubMed ID: 4120147
    [No Abstract]   [Full Text] [Related]  

  • 39. [Problems of cell cooperation in the humoral immune reaction].
    Rajewsky K
    Allerg Immunol (Leipz); 1973; 19(2-4):122-30. PubMed ID: 4141863
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific selection of cytotoxic effector cells: the generation of cytotoxic T cells in rat thoracic duct lymphocyte populations positively or negatively selected for reactivity to specific strong histocompatibility alloantigens.
    Wilson DB; Marshak A; Razzino-Pierson G; Howard JC
    J Immunol; 1976 Jun; 116(6):1624-8. PubMed ID: 58040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.